Seeking Alpha

Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the...

Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the year-ago period and better than analyst estimates of $0.49, and a 65% rise in profit on strong sales of its LifeVest device. The maker of defibrillators forecasts 2012 revenue will rise as much as 19% vs. analyst consensus of ~16%, and reports a $50M share buyback program.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs